publicationMetadata:
  pmid: "29897904"
  title: "Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2."
  queryType: "bench"
  publicationType: "Lab Research"
  publicationTypeConfidence: 1.0
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    This is a comprehensive laboratory research study that should contain multiple tool categories:
    - Cell lines: Multiple human and mouse cell lines are described (Syn1-Syn12, HS01, HS11, MS01-MS12)
    - Animal models: Genetically engineered mouse models (PostnCre; Nf2^flox/flox)
    - Genetic reagents: CRISPR/Cas9 constructs, shRNA constructs
    - Computational tools: RNA sequencing analysis, bioinformatics pipelines, statistical software
    
    This publication represents a multi-institutional drug discovery effort with extensive experimental
    methodology that would typically use dozens of research tools across multiple categories.
  overallAssessment: |
    This publication is a comprehensive laboratory research study from the Synodos for NF2 Consortium
    involving drug screening, cell culture, animal models, transcriptome analysis, and kinome profiling.
    The study clearly describes experimental methods and should contain numerous research tools including
    cell lines, animal models, genetic reagents, and computational tools. The complete absence of mined
    tools represents a major failure in the mining process.

toolValidations: []

potentiallyMissedTools:
  - toolName: "Syn1"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "These included 5 isogenic clonally-derived arachnoidal cell (AC-CRISPR) lines, of which two are merlin-wildtype controls (Syn1 and Syn2)"
    whyMissed: "Cell line naming convention not recognized - systematic naming Syn1-Syn12"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Syn2"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "These included 5 isogenic clonally-derived arachnoidal cell (AC-CRISPR) lines, of which two are merlin-wildtype controls (Syn1 and Syn2)"
    whyMissed: "Cell line naming convention not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Syn3"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "three are merlin-deficient lines generated by CRISPR/Cas9 NF2 inactivation (Syn3, Syn4, and Syn5)"
    whyMissed: "Cell line naming convention not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Syn4"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "three are merlin-deficient lines generated by CRISPR/Cas9 NF2 inactivation (Syn3, Syn4, and Syn5)"
    whyMissed: "Cell line naming convention not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Syn5"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "three are merlin-deficient lines generated by CRISPR/Cas9 NF2 inactivation (Syn3, Syn4, and Syn5)"
    whyMissed: "Cell line naming convention not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Ben-Men-1"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "along with the immortalized merlin-deficient benign meningioma (MN) line Ben-Men-1 (Syn6)"
    whyMissed: "Established cell line name not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "HS01"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "human fetal Schwann cell (SC) lines, (HS11, wild-type) and (HS01, NF2-shRNA suppressed"
    whyMissed: "Cell line naming convention not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "HS11"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "human fetal Schwann cell (SC) lines, (HS11, wild-type) and (HS01, NF2-shRNA suppressed"
    whyMissed: "Cell line naming convention not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "MS01"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "Mouse Schwann cell Nf2 ex2-/- n/a Deficient"
    whyMissed: "Cell line naming convention not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "MS02"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "Mouse schwannoma cell Nf2 ex2-/- n/a Deficient"
    whyMissed: "Cell line naming convention not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "MS03"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "Mouse Schwann cell Nf2 ex2-/- n/a Deficient"
    whyMissed: "Cell line naming convention not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "MS11"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "Mouse Schwann cell n/a Wildtype"
    whyMissed: "Cell line naming convention not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "MS12"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "mouse Schwann cell Nf2 fl2/fl2 n/a Wildtype"
    whyMissed: "Cell line naming convention not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "PostnCre; Nf2^flox/flox"
    toolType: "animal_model"
    foundIn: "results"
    contextSnippet: "genetically-engineered mouse (GEM) model of NF2, PostnCre; Nf2^flox/flox, that develops schwannoma of the dorsal root ganglia"
    whyMissed: "Mouse strain nomenclature not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "CRISPR/Cas9"
    toolType: "genetic_reagent"
    foundIn: "results"
    contextSnippet: "merlin-deficient lines generated by CRISPR/Cas9 NF2 inactivation"
    whyMissed: "CRISPR system not recognized as genetic reagent"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "NF2 shRNA"
    toolType: "genetic_reagent"
    foundIn: "results"
    contextSnippet: "HS01, NF2-shRNA suppressed with ~3% merlin protein expression"
    whyMissed: "shRNA construct not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "CellTiter-Glo"
    toolType: "genetic_reagent"
    foundIn: "results"
    contextSnippet: "Dose response curves (DRCs) were generated for all meningioma-relevant (Syn1â€“Syn12) and schwannoma-relevant (HS01, HS11, MS01-MS12) cell lines using the CellTiter-Glo"
    whyMissed: "Commercial assay reagent not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "CellTiter-Fluor"
    toolType: "genetic_reagent"
    foundIn: "results"
    contextSnippet: "cell viability was assessed with CellTiter-Fluor at 48 hours"
    whyMissed: "Commercial assay reagent not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "RNA sequencing"
    toolType: "computational_tool"
    foundIn: "results"
    contextSnippet: "we performed RNA sequencing (RNAseq). Principal components analysis (PCA) of rank-normalized gene counts"
    whyMissed: "RNA-seq analysis pipeline not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "DAVID"
    toolType: "computational_tool"
    foundIn: "results"
    contextSnippet: "Pathway analysis of gene ontology (GO) terms with the Database for Annotation, Visualization and Integrated Discovery (DAVID)"
    whyMissed: "Bioinformatics database/tool not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Drug Gene Interaction database"
    toolType: "computational_tool"
    foundIn: "results"
    contextSnippet: "based upon the Drug Gene Interaction database (http://dgidb.genome.wustl.edu/)"
    whyMissed: "Bioinformatics database not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "string-db.org"
    toolType: "computational_tool"
    foundIn: "results"
    contextSnippet: "we also queried a protein interaction database (string-db.org) for potential subnetworks"
    whyMissed: "Protein interaction database not recognized"
    confidence: 1.0
    shouldBeAdded: Yes

suggestedPatterns:
  - patternType: "naming_convention"
    pattern: "Syn[0-9]+"
    toolType: "cell_line"
    examples: ["Syn1", "Syn2", "Syn3", "Syn4", "Syn5", "Syn6", "Syn7", "Syn8", "Syn9", "Syn10", "Syn11", "Syn12"]
    reasoning: "Systematic cell line naming used in this consortium study - Syn followed by numbers"

  - patternType: "naming_convention"
    pattern: "[HM]S[0-9]+"
    toolType: "cell_line"
    examples: ["HS01", "HS11", "MS01", "MS02", "MS03", "MS11", "MS12"]
    reasoning: "Human Schwann (HS) and Mouse Schwann (MS) cell line naming convention"

  - patternType: "naming_convention"
    pattern: "Ben-Men-[0-9]+"
    toolType: "cell_line"
    examples: ["Ben-Men-1"]
    reasoning: "Established meningioma cell line naming pattern"

  - patternType: "naming_convention"
    pattern: "[A-Za-z]+Cre;\\s*[A-Za-z0-9]+\\^?[a-z]+/[a-z]+"
    toolType: "animal_model"
    examples: ["PostnCre; Nf2^flox/flox"]
    reasoning: "Mouse strain nomenclature with Cre driver and floxed alleles"

  - patternType: "term"
    pattern: "CRISPR/Cas9"
    toolType: "genetic_reagent"
    examples: ["CRISPR/Cas9 NF2 inactivation"]
    reasoning: "CRISPR gene editing system should be recognized as genetic reagent"

  - patternType: "term"
    pattern: "[A-Z0-9]+\\s+shRNA"
    toolType: "genetic_reagent"
    examples: ["NF2 shRNA"]
    reasoning: "Gene-specific shRNA constructs are genetic reagents"

  - patternType: "term"
    pattern: "CellTiter-[A-Za-z]+"
    toolType: "genetic_reagent"
    examples: ["CellTiter-Glo", "CellTiter-Fluor"]
    reasoning: "Commercial cell viability assay reagents"

  - patternType: "term"
    pattern: "RNA sequencing|RNAseq|RNA-seq"
    toolType: "computational_tool"
    examples: ["RNA sequencing (RNAseq)"]
    reasoning: "RNA sequencing analysis should be recognized as computational tool"

  - patternType: "context_phrase"
    pattern: "Database for Annotation, Visualization and Integrated Discovery \\(DAVID\\)"
    toolType: "computational_tool"
    examples: ["DAVID"]
    reasoning: "DAVID is a well-known bioinformatics analysis tool"

  - patternType: "context_phrase"
    pattern: "protein interaction database \\([^)]+\\)"
    toolType: "computational_tool"
    examples: ["string-db.org"]
    reasoning: "Protein interaction databases used for analysis"

observations:
  - resourceName: "Syn1"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: ""
    details: |
      Merlin-wildtype control arachnoidal cell line showed similar growth rates to other isogenic 
      clonally-derived AC-CRISPR lines (Syn1-Syn5). Expressed merlin band at ~70 kDa by Western blot.
    foundIn: "results"
    contextSnippet: "Similar growth rates were observed among the isogenic clonally-derived AC-CRISPR lines (Syn1-Syn5)... All control AC and SC lines expressed a merlin band at ~70 kDa by Western blot"
    confidence: 1.0
    doi: "10.1371/journal.pone.0197350"

  - resourceName: "Syn3"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: ""
    details: |
      Merlin-deficient arachnoidal cell line generated by CRISPR/Cas9 NF2 inactivation. Failed to 
      exhibit merlin protein by Western blot, confirming successful NF2 knockout.
    foundIn: "results"
    contextSnippet: "merlin-deficient lines generated by CRISPR/Cas9 NF2 inactivation (Syn3, Syn4, and Syn5)... human and mouse cell lines with NF2 or Nf2 inactivation, respectively, failed to exhibit merlin protein"
    confidence: 1.0
    doi: "10.1371/journal.pone.0197350"

  - resourceName: "Syn4"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: ""
    details: |
      Merlin-deficient arachnoidal cell line generated by CRISPR/Cas9 NF2 inactivation. Failed to 
      exhibit merlin protein by Western blot, confirming successful NF2 knockout.
    foundIn: "results"
    contextSnippet: "merlin-deficient lines generated by CRISPR/Cas9 NF2 inactivation (Syn3, Syn4, and Syn5)... human and mouse cell lines with NF2 or Nf2 inactivation, respectively, failed to exhibit merlin protein"
    confidence: 1.0
    doi: "10.1371/journal.pone.0197350"

  - resourceName: "Syn5"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: ""
    details: |
      Merlin-deficient arachnoidal cell line generated by CRISPR/Cas9 NF2 inactivation. Failed to 
      exhibit merlin protein by Western blot. Showed increased MIB binding of receptor tyrosine kinases 
      such as EPH receptor proteins B1 and A4, KIT, and FLT1/VEGFR1, and RPS6KB1/p70S6K compared to 
      isogenic merlin-wildtype Syn1 cells.
    foundIn: "results"
    contextSnippet: "merlin-deficient Syn5 AC showed increased MIB binding of receptor tyrosine kinases such as EPH receptor proteins B1 and A4, KIT, and FLT1/VEGFR1, and RPS6KB1/p70S6K as compared to the isogenic merlin-wildtype Syn1 cells"
    confidence: 1.0
    doi: "10.1371/journal.pone.0197350"

  - resourceName: "HS01"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: ""
    details: |
      Human fetal Schwann cell line with NF2-shRNA suppression showing ~3% merlin protein expression 
      by Western blotting and ~7% RNA expression by RNA sequencing versus wild-type. Showed increased 
      binding of EPH receptor EPHA3 and Unc51-like kinase ULK4 compared to wild-type HS11.
    foundIn: "results"
    contextSnippet: "HS01, NF2-shRNA suppressed with ~3% merlin protein expression by Western blotting and ~7% RNA expression by RNA sequencing versus wild-type... merlin-suppressed HS01 SC line had increased binding of EPH receptor EPHA3, and the Unc51-like kinase ULK4"
    confidence: 1.0
    doi: "10.1371/journal.pone.0197350"

  - resourceName: "PostnCre; Nf2^flox/flox"
    resourceType: "Animal Model"
    observationType: "Tumor Growth"
    observationTypeOntologyId: "MP:0002006"
    details: |
      Genetically-engineered mouse model develops schwannoma of the dorsal root ganglia (DRG) and 
      cranial nerves. Median tumor size was not reduced in response to GSK2126458, Panobinostat, 
      or CUDC-907 treatment. Progressive decline in hearing threshold as measured by ABR regardless 
      of drug treatment. Histologic examination showed comparable disrupted architecture consistent 
      with schwannoma irrespective of treatment.
    foundIn: "results"
    contextSnippet: "genetically-engineered mouse (GEM) model of NF2, PostnCre; Nf2^flox/flox, that develops schwannoma of the dorsal root ganglia (DRG) and cranial nerves... Median tumor size was not reduced in response to any of the three experimental drugs... there was a progressive decline in hearing threshold as measured by ABR regardless of drug used"
    confidence: 1.0
    doi: "10.1371/journal.pone.0197350"

  - resourceName: "Ben-Men-1"
    resourceType: "Cell Line"
    observationType: "Tumor Growth"
    observationTypeOntologyId: "MP:0002006"
    details: |
      Immortalized merlin-deficient benign meningioma cell line. In orthotopic xenograft model, 
      GSK2126458 treatment resulted in ~56% tumor growth suppression relative to vehicle-treated 
      tumors at four months. Panobinostat prevented tumor growth with >400% growth suppression 
      versus vehicle controls. CUDC-907 showed 55% reduction in tumor size after 14 weeks of treatment.
    foundIn: "results"
    contextSnippet: "GSK2126458 suppressed tumor growth by an average of ~56% relative to vehicle-treated tumors at four months... Meningioma xenografts treated with Panobinostat did not grow following treatment, and the magnitude of growth suppression became more significant over time versus vehicle-treated tumors which grew more than 400%... CUDC-907 at 25 mg/kg/day resulted in a trend of suppression of tumor growth compared with vehicle-treated controls after ten weeks with an average reduction of 55% in tumor size after 14 weeks"
    confidence: 1.0
    doi: "10.1371/journal.pone.0197350"

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 21
  newPatternsCount: 10
  observationsExtracted: 7
  observationsByType:
    Cellular: 5
    Tumor Growth: 2
  majorIssuesFound: |
    - COMPLETE MINING FAILURE: No tools were mined from this comprehensive laboratory research study
    - This publication contains extensive experimental methodology with multiple cell lines, animal models, genetic reagents, and computational tools
    - At least 21 clear research tools were identified that should have been captured
    - The mining system failed to recognize standard cell line naming conventions (Syn1-12, HS01/11, MS01-12)
    - Failed to identify established cell lines (Ben-Men-1)
    - Failed to recognize mouse strain nomenclature (PostnCre; Nf2^flox/flox)
    - Failed to identify genetic reagents (CRISPR/Cas9, shRNA constructs)
    - Failed to recognize computational tools and databases (DAVID, STRING-DB, RNA-seq)
    - Failed to identify commercial reagents (CellTiter-Glo, CellTiter-Fluor)
  recommendations: |
    URGENT MINING SYSTEM OVERHAUL NEEDED:
    - This represents a catastrophic failure of the mining system on a publication that should be a "gold standard" example
    - All 21 identified tools should be added to the database
    - The 10 suggested patterns should be implemented immediately to prevent similar failures
    - Cell line naming conventions need major improvement - consortium studies often use systematic naming
    - Mouse strain nomenclature recognition needs enhancement
    - CRISPR/Cas9 and shRNA should be standard genetic reagent patterns
    - Commercial assay reagents should be recognized
    - Bioinformatics tools and databases need better coverage
    - This publication demonstrates the need for comprehensive pattern testing on known tool-rich publications
    - Consider manual curation of high-impact consortium publications like this one
    - The extracted observations show rich phenotypic data that validates the importance of these tools
